The Clorox Company (NYSE:CLX) Stock Holdings Cut by Chevy Chase Trust Holdings LLC

Chevy Chase Trust Holdings LLC cut its position in shares of The Clorox Company (NYSE:CLX - Free Report) by 2.0% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 87,835 shares of the company's stock after selling 1,748 shares during the quarter. Chevy Chase Trust Holdings LLC owned 0.07% of Clorox worth $14,265,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. State Street Corp raised its holdings in Clorox by 3.1% during the third quarter. State Street Corp now owns 8,182,109 shares of the company's stock worth $1,332,947,000 after purchasing an additional 245,525 shares during the last quarter. Mizuho Securities USA LLC raised its holdings in Clorox by 46,877.8% during the third quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company's stock worth $733,095,000 after purchasing an additional 4,490,421 shares during the last quarter. Geode Capital Management LLC raised its holdings in Clorox by 1.1% during the third quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company's stock worth $491,713,000 after purchasing an additional 33,970 shares during the last quarter. Stifel Financial Corp raised its holdings in Clorox by 1.7% during the third quarter. Stifel Financial Corp now owns 2,334,826 shares of the company's stock worth $380,370,000 after purchasing an additional 37,967 shares during the last quarter. Finally, Van ECK Associates Corp raised its holdings in shares of Clorox by 2.2% in the third quarter. Van ECK Associates Corp now owns 1,492,717 shares of the company's stock worth $237,372,000 after acquiring an additional 31,510 shares during the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on CLX. DA Davidson cut their price target on Clorox from $171.00 to $169.00 and set a "neutral" rating for the company in a report on Wednesday, February 5th. TD Cowen raised Clorox from a "sell" rating to a "hold" rating and boosted their price target for the stock from $155.00 to $170.00 in a report on Wednesday, November 6th. Evercore ISI boosted their price target on Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. Wells Fargo & Company boosted their price target on Clorox from $157.00 to $161.00 and gave the stock an "equal weight" rating in a report on Tuesday, February 4th. Finally, JPMorgan Chase & Co. upped their target price on Clorox from $171.00 to $173.00 and gave the company a "neutral" rating in a research note on Tuesday, February 4th. Four analysts have rated the stock with a sell rating, eleven have given a hold rating and one has given a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $158.21.

Clorox Stock Performance

Shares of Clorox stock traded up $1.84 on Thursday, reaching $152.93. 1,382,160 shares of the company were exchanged, compared to its average volume of 1,322,812. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The company's 50-day moving average is $158.11 and its two-hundred day moving average is $159.68. The firm has a market cap of $18.84 billion, a price-to-earnings ratio of 41.78, a P/E/G ratio of 2.54 and a beta of 0.42. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, topping analysts' consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter in the previous year, the business posted $2.16 EPS. As a group, research analysts expect that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.